Solopharm

Solopharm
Solopharm
Industry	Pharmaceuticals
Founded	2010

Solopharm (Grotex OOO) is a Russian pharmaceutical company that produces liquid sterile dosage forms according to GMP standards (license No. 00023-LS). The company manufactures infusion and injection solutions, ophthalmic, otolaryngological, gastroenterological, rheumatological and cosmetological products.

History

Solopharm was established in 2010 by Russian businessman, Oleg Zherebtsov. In August 2014, the company launched injection and infusion solution technology Blow-Fill-Seal. Solopharm company continues building and assembling new lines to increase the amount of liquid medicines in ophthalmology, otolaryngology, gastroenterology, rheumatology and cosmetology.

Activity

The company activity is directed to development and production of:

Products in polyethylene and polypropylene packaging
Generics in different therapeutic areas
Own brands of drugs and medical products

Product Lines

Ophthalmology
Rheumatology
Otolaryngology
Pulmonology
Cosmetology
Gastroenterology
Injection solutions
Infusion solutions

References

↑ "Фармзавод Solopharm инвестирует 32 млн евро в строительство третьей очереди". Фармацевтический вестник. 2015-09-22. Archived from the original on 2016-03-05. Retrieved 2016-04-18.
↑ Елена Кром, Наталья Доброва (2015-05-15). "О.Жеребцов: от продуктового ретейла до производства вакцин". РБК. Archived from the original on 2016-03-05. Retrieved 2016-04-16.
↑ Богдан Боколейко (2015-10-05). "Первая конференция компании Solopharm для СМИ. Репортаж канала Санкт-Петербург". Бизнес Петербург. Archived from the original on 2016-03-05. Retrieved 2016-04-18.
↑ "Два инвестиционных проекта получили статус стратегических". Новотека. 2016-01-11. Archived from the original on 2016-03-05. Retrieved 2016-04-18.

External links

Solopharm website

This Russian corporation or company article is a stub. You can help Wikipedia by adding missing information.

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by adding missing information.

[1] "Фармзавод Solopharm инвестирует 32 млн евро в строительство третьей очереди". Фармацевтический вестник. 2015-09-22. Archived from the original on 2016-03-05. Retrieved 2016-04-18.

[2] Елена Кром, Наталья Доброва (2015-05-15). "О.Жеребцов: от продуктового ретейла до производства вакцин". РБК. Archived from the original on 2016-03-05. Retrieved 2016-04-16.

[3] Богдан Боколейко (2015-10-05). "Первая конференция компании Solopharm для СМИ. Репортаж канала Санкт-Петербург". Бизнес Петербург. Archived from the original on 2016-03-05. Retrieved 2016-04-18.

[4] "Два инвестиционных проекта получили статус стратегических". Новотека. 2016-01-11. Archived from the original on 2016-03-05. Retrieved 2016-04-18.